Communicable Disease Management Protocols

Introduction:  Purpose of the Manual

The prevention, management and control of communicable diseases requires the active participation and cooperation of all health-care professionals and practitioners.

While this manual is intended to act as a guide to the management and control of communicable diseases within the Province of Manitoba, professional judgment will still be required by those charged with providing health care services.

Protocols for specific communicable diseases contain epidemiologic information with reference to provincial and national trends. Detailed information related to laboratory testing, treatment and public health investigation is included in the protocols and reflects best practices at the time of release. As advances in scientific knowledge and health care practices become available, our collective response to well established as well as newly identified and evolving pathogens must be routinely reviewed and updated. Although the Manual will be updated periodically, practitioners must take responsibility to ensure that they have the most recent knowledge relating to the case they are dealing with and, for that reason, a list of resources has been included below.

The most current versions of the following publications:

• Canadian Immunization Guide – Public Health Agency of Canada
• Control of Communicable Diseases Manual – American Public Health Association
• Principles and Practices of Infectious Diseases – Elsevier
• Redbook: Report of the Committee on Infectious Diseases - American Academy of Pediatrics

The following organizations:

• Infectious Diseases Society of America (Practice Guidelines)
• Public Health Agency of Canada
• UpToDate
• US Centers for Disease Control and Prevention
• US National Institutes of Health
• World Health Organization

Most recent additions:

	Malaria (July 2017) REVISED
	Tetanus (July 2017) REVISED
	Severe Acute Respiratory Infection (SARI) and Emerging Respiratory Pathogens (December 2016) NEW
	Creutzfeldt-Jakob Disease (CJD) (December 2016) REVISED
	Tularemia (Francisella tularensis) (November 2016) REVISED
	Botulism (October 2016) REVISED
	Seasonal Influenza (August 2016) REVISED
	Diphtheria (August 2016) REVISED
	Streptococcal Group B Invasive Disease of the Newborn (August 2016) REVISED
	Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (August 2016) REVISED
	Anaplasmosis (May 2016) NEW
	Babesiosis (May 2016) NEW
	Q Fever (Coxiella burnetii) (April 2016) NEW
	Cyclosporiasis (March 2016) NEW

---

Table of Contents

• Communicable Disease Surveillance
• Epidemiological Investigation of Outbreaks
• Control of Enteric Infections
• Reportable Diseases and Conditions by Health Professionals (HP) and Labs (L)  (April 2009)
• The Public Health Act Reporting Powers and Requirements  (May 2008)

Protocols:

Click on any of the underlined letters in the yellow bar to jump to a particular topic, or hit CTRL + F to search for a keyword.

Amebiasis (February 2013)

Anaplasmosis (May 2016)

Anthrax (August 2012)

Antibiotic Resistant Organisms
         See:

Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (August 2016) REVISED

Babesiosis (May 2016)

Blastomycosis (September 2007)

Botulism (November 2012 with October 2016 update)
         See also:

The following link is to the product information leaflet for the product that Manitoba Health may have available. Please ensure the correct leaflet is reviewed based on the product received.

Cangene heptavalent (A, B, C, D, E, F, G)

Brucellosis (November 2001)

Campylobacter Infection (February 2012)

Chancroid (November 2001)

Children with Sexually Transmitted Diseases (STDs) (November 2001)

Chlamydia trachomatis (D through K Serovars) Infection (April 2008, with August 2015 update)

Cholera (November 2001)

Clostridium difficile-Associated Diseases (CDAD) (September 2006)

Creutzfeldt-Jakob Disease (CJD) (December 2016) REVISED

Cryptosporidiosis (July 2013)

Cyclosporiasis (March 2016) NEW

Diphtheria (August 2016) REVISED

Ebola Virus Disease (EVD) Interim Protocol (March 2015) REVISED

	Ebola Virus Disease (EVD) Environmental Cleaning/Disinfection Guidelines for Community Settings (June 2017) REVISED
	Ebola Virus Disease (EVD) Infection Prevention and Control Interim Guidelines (March 2015) REVISED
	Ebola Virus Disease (EVD) Infection Prevention and Control Interim Guidelines for PreHospital Settings (April 2015) NEW
	Ebola Virus Disease (EVD) Public Health Contact Management Interim Guidelines (June 2017) REVISED

Interim Protocol for Handling Human Remains Infected with Ebola Virus (September 2015) NEW

Enteric Illness Protocol (March 2008)

Giardiasis (September 2013)

Gonorrhea (August 2015) REVISED

Haemophilus influenzae Disease (October 2007)

Hantavirus Pulmonary Syndrome (August 2015) REVISED

Hepatitis A (February 2014) REVISED

Hepatitis B (July 2013)
         See also:

	Hepatitis B Newborn Prophylaxis Letter Templates (June 2016)
	Hepatitis B Newborn Prophylaxis Protocols (July 2013)
	Integrated Post-Exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids (March 2009)
	Sexually Transmitted and Bloodborne Infections

Hepatitis C (December 2014)
         See also:

Integrated Post-Exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids (March 2009)

Sexually Transmitted and Bloodborne Infections

Herpes Zoster (Shingles) (June 2014)

Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) (February 2010)
         See also:

Integrated Post-Exposure Protocol for HIV, HBV and HCV: Guidelines for Managing Exposures to Blood and Body Fluids (March 2009; revised August 2016)

Sexually Transmitted and Bloodborne Infections

Seasonal Influenza (August 2016) REVISED
         See also:

Seasonal Flu (The Flu) (July 2012)

Invasive Meningococcal Disease (Neisseria meningitidis) (June 2011)
         See also:

Meningococcal Post Exposure Prophylaxis Invoicing Process (April 2013)

Invasive Pneumococcal Disease (Streptococcus pneumoniae) (Pneumococcus) (January 2011)

Legionellosis (revised March 2015)

Leprosy (November 2001)

Listeriosis (June 2011)

Lyme Disease (revised February 2013)

Lymphogranuloma Venereum (LGV) (May 2007)

Malaria (July 2017)

Measles (Rubeola) (July 2010)

Methicillin and Vancomycin Resistant Staphylococcus aureus (MRSA/VRSA) Infection
        See:

Manitoba Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (January 2007)

Mumps (July 2010)

Pediculosis Capitis (Head Lice) (July 2014)

Pertussis/Parapertussis (November 2007)

Plague (November 2001)
         See also:

• Recommended Guidelines for Suspected Plague Cases at Winnipeg International Airport (September 1997)

Poliovirus Infections (November 2001)

Q Fever (Coxiella burnetii) (April 2016) NEW

Rabies:  Protocol for Management of Human Rabies and Management of Animal Exposures to Prevent Human Rabies (with April 2014 and January 2016 updates) REVISED

Rubella and Congenital Rubella Syndrome/Infection (November 2010)

Salmonellosis (Non-Typhoid) (November 2011)

Seasonal Influenza (August 2016)

Severe Acute Respiratory Infection (SARI) and Emerging Respiratory Pathogens (December 2016) NEW

Sexually Transmitted Infections Treatment Guidelines
     The Sexually Transmitted Infections Treatment Guidelines have been archived. 
      Please refer to these disease specific protocols for treatment recommendations:

• Chancroid (November 2001)
• Chlamydia trachomatis (D through K Serovars) Infection (April 2008)
• Gonorrhea (April 2008 with July 2013 update)
• Lymphogranuloma Venereum (LGV) (May 2007)
• Syphilis (July 2014)

         See also:

• STI Medication Order Form (September 2015)

Shigellosis (November 2011)

Streptococcal Disease (Group A Invasive) (November 2007)

Streptococcal (Group B) Invasive Disease of the Newborn (August 2016) REVISED

Syphilis (July 2014)
         See also:

Sexually Transmitted and Bloodborne Infections

Tetanus (July 2017)

See also:

The following link is to the product information leaflet for the product that Manitoba Health may have available. Please ensure the correct leaflet is reviewed based on the product received.

Tetanus Immune Globulin (Human)

Travel Health (January 2015)

Manitoba Tuberculosis Protocol (February 2014)
     See also:

Manitoba Tuberculosis Program - Roles and Responsibilities Matrix (January 2014)

Tularemia (Francisella tularensis) (November 2016)

Typhoid and Paratyphoid Fever (Enteric Fever) (October 2012)

Vancomycin Resistant Enterococci (VRE)
         See:

Manitoba Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (January 2007)

Vancomycin Resistant Staphylococcus aureus
         See:

Manitoba Guidelines for the Prevention and Control of Antibiotic Resistant Organisms (AROs) (January 2007)

Varicella (Chickenpox) (June 2014)

Verotoxigenic Escherichia coli (VTEC) Infection (May 2007)

West Nile virus Public Health Human Case Investigation Protocol (July 2015)

Yellow Fever (November 2001)

Yersiniosis (February 2012)

• For Surveillance forms, click here.
  
  
• Hepatitis B Prophylaxis Record Sheet for Infants
  (November 2008)
• HIV Post-Exposure Prophylaxis Drug Order Form
  (August 2016)
• Information Record:  HIV Post-Exposure Prophylaxis
  (March 2009)
• Instructions for STD Medication Administration Form
• Interregional Referral for Public Health Service
  (Nov 2012)
• Meningococcal Contact Form
  (Revised December 2005)
• Report of Suspected Rabies Exposure
  (Revised October 2016)
• STI Medication Order Form
  (September 2015)
• STI Medication Administration Form
  (Revised June 2015)
• Vaccines and Biologics Order Form
  (Revised July 2016)